We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

101 hedge funds and large institutions have $20.5M invested in Definium Therapeutics in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more call options, than puts

Call options by funds: $20.9M | Put options by funds: $6.14M

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

37% more capital invested

Capital invested by funds: $14.9M → $20.5M (+$5.59M)

19.01% more ownership

Funds ownership: 0.36% → 19.37% (+19%)

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

35% less funds holding

Funds holding: 155 → 101 (-54)

75% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 72

Holders
101
Holders Change
-54
Holders Change %
-34.84%
% of All Funds
1.74%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
18
Increased
34
Reduced
34
Closed
72
Calls
$20.9M
Puts
$6.14M
Net Calls
+$14.7M
Net Calls Change
+$13.7M

Top Buyers

1
DCI
Data Collective IV
California
+$13.5M
2
MFG
Merit Financial Group
Georgia
+$10M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$9.6M
4
CH
CVI Holdings
Delaware
+$6.26M
5
EAM
Empery Asset Management
New York
+$1.8M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$1.76M
2
E
Ergoteles
New York
-$696K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$405K
4
LPL Financial
LPL Financial
California
-$324K
5
PCM
Penserra Capital Management
California
-$282K
Name Holding Trade Value Shares
Change 		Change in
Stake
DCI
1
Data Collective IV
California
$5.22M +$13.5M +1,404,898 +1,400%
MFG
2
Merit Financial Group
Georgia
$3.78M +$10M +1,045,082 +2,945%
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$3.5M +$9.6M +1,000,000 New
CH
4
CVI Holdings
Delaware
$2.28M +$6.26M +652,374 New
BB
5
Busey Bank
Illinois
$855K +$1.55M +161,134 +194%
EAM
6
Empery Asset Management
New York
$656K +$1.8M +187,500 New
Millennium Management
7
Millennium Management
New York
$542K -$1.76M -183,442 -54%
TI
8
Telemetry Investments
New York
$369K +$1.01M +105,500 New
Citadel Advisors
9
Citadel Advisors
Florida
$304K -$280K -29,185 -25%
Group One Trading
10
Group One Trading
Illinois
$219K +$238K +24,743 +65%
AI
11
AdvisorShares Investments
Maryland
$210K +$95.4K +9,942 +20%
Swiss National Bank
12
Swiss National Bank
Switzerland
$198K – – –
Bank of America
13
Bank of America
North Carolina
$194K +$465K +48,463 +685%
State Street
14
State Street
Massachusetts
$189K -$98.7K -10,280 -16%
KPWS
15
Kestra Private Wealth Services
Texas
$177K +$485K +50,472 New
FC
16
Fore Capital
New York
$168K +$358K +37,332 +350%
CSS
17
Cubist Systematic Strategies
Connecticut
$155K +$97.3K +10,132 +30%
Jane Street
18
Jane Street
New York
$144K +$269K +28,030 +207%
VF
19
Virtu Financial
New York
$126K +$345K +35,910 New
Simplex Trading
20
Simplex Trading
Illinois
$120K +$323K +33,661 +4,574%
BlackRock
21
BlackRock
New York
$107K +$160K +16,641 +120%
Wolverine Trading
22
Wolverine Trading
Illinois
$103K +$287K +29,939 New
Morgan Stanley
23
Morgan Stanley
New York
$92K -$213K -22,221 -46%
CS
24
Credit Suisse
Switzerland
$78K +$9.5K +990 +5%
UBS Group
25
UBS Group
Switzerland
$78K +$196K +20,451 +1,139%
1
2 3 4 5

DFTX Hedge Fund Activity: Q3 2022 in Review

101 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q3 2022, worth a combined $20.5M — up 37% from $14.9M a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of DFTX and 18 opened new positions — a net loss of 54 holders — while 34 trimmed existing stakes and 34 added.

The largest buyer was Data Collective IV, adding an estimated $13.5M. The largest seller was Millennium Management, cutting an estimated $1.76M.

  • 101 institutional investors held Definium Therapeutics (DFTX) as of Q3 2022, down from 155 in Q2 2022.
  • Funds reported $20.5M of Definium Therapeutics stock for Q3 2022, up 37% quarter-over-quarter.
  • 18 funds opened new Definium Therapeutics positions in Q3 2022 and 72 closed out, a net change of -54 holders.
  • The largest Definium Therapeutics buyer in Q3 2022 was Data Collective IV, an estimated $13.5M added.
  • The largest Definium Therapeutics seller in Q3 2022 was Millennium Management, an estimated $1.76M sold.

Based on aggregated 13F filings for Q3 2022.